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Background: Prenatal use of traditional medicine or complementary and alternative medicine is widespread
globally despite the lack of evidence of the effectiveness of these therapeutic options. Documentation on the
prevalence and patterns of this maternal practice in the Zimbabwean setting was also lacking.
Methods: A cross sectional survey of 248 women at selected health centres in Harare was carried out to address
the need for such data using an interviewer-administered questionnaire.
Results: Fifty-two (52%) (95% C.I. 44%-60%) of the participants reported to have used at least one traditional
medicine intervention during the third trimester of their most recent pregnancy to induce labour, avoid perineal
tearing and improve the safety of their delivery process. The study found prenatal use of traditional medicine to be
significantly associated with nulliparity and nulligravidity. Such practice was also significant among participants
residing in a particular high density suburb located in close proximity to informal traders of traditional medicines.
Prenatal traditional medicine use was not significantly linked to experiencing an obstetrics-related adverse event.
Instead, participants who reported not using any traditional medicine during pregnancy reported experiencing
significantly more adverse events, mainly perineal tearing during delivery.
Conclusions: The practice of prenatal use of traditional medicine was significant in the study setting, with a
prevalence of 52%. A variety of products were used in various dosage forms for differing indications. Nulliparity,
nulligavidity and possible accessibility of these products were the factors significantly associated with prenatal use
of traditional medicine. Prenatal use of traditional medicine was not significantly associated with any obstetric
adverse event.
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Traditional medicine (TM) is defined as, “the sum total
of knowledge, skills and practices based on the theories,
beliefs and experiences indigenous to different cultures
that are used to maintain health, as well as to prevent,
diagnose, improve or treat physical and mental illnesses”
[1]. Prenatal use of TM is widespread globally despite
the lack of evidence of its safety. Some literature even
suggested the lack of safety of prenatal use of TM [2],
[3]. Investigators in a clinical trial testing the effective-
ness of early application of a non-pneumatic anti-shock* Correspondence: cmaponga@medsch.uz.ac.zw
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reproduction in any medium, provided the orgarment for obstetric haemorrhage (NASG) at a satellite
health facility in Zimbabwe hypothesized that the pre-
natal use of some TMs especially Cannabis sativa was
linked to post-partum haemorrhage and uterine rupture.
The investigators requested the authors to find out the
mechanism of action of these TMs. A preliminary cross-
sectional study to validate these anecdotal claims was
required before any in-vitro studies to discover the
mechanism of action of these TMs could be designed.
The objectives of this study were to; 1) determine the
prevalence of prenatal use of TM within a sample of
women drawn from selected clinics, 2) find out the most
commonly used traditional medicines, 3) determine
which factors were significantly associated with theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Data Collection Tool.
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was significantly associated with obstetric-related ad-
verse events such as perineal tearing. Identification of
the most commonly used traditional medicines would
then form the basis for further studies to address the
query that had been raised by the NASG team.
Methods
A cross-sectional study design was chosen as the best
observational method to determine prevalence and asso-
ciations [4]. Twelve Harare public maternity clinics from
where participants of the NASG clinical trial were being
drawn were selected as the study sites. Participants were
drawn from women who presented at the study sites for
the mandatory six weeks postnatal reviews between 1
November 2010 and 31 March 2011. An interviewer-
administered questionnaire (see Figure 1), was used to col-
lect data from eligible participants after the study’s work-
ing definition of “Traditional Medicine” was explained to
them. This questionnaire was formulated by modifying
the one used by Rahman and co-workers [5]. The ques-
tionnaire was then piloted among 20 participants before
being adopted as the study’s data collection tool. The sam-
ple size of at least 246 was calculated to enable estimation
of the proportion of women who used traditional medi-
cines during the prenatal period at a 95% confidence level,
allowing for a 5% margin of error. This was after the pilot
study revealed that 80%of the population of interest uti-
lised traditional medicines during the prenatal period. Eli-
gible participants were Shona or English speaking women
visiting the study sites for their six weeks postnatal reviews
during the specified period, who were able to give their
full informed consent. The six-week period was regarded
as long enough to allow the participants to recover from
the birthing experience yet short enough post-delivery to
avoid recall bias among the participants. At least 20 parti-
cipants were recruited from each site. Before sampling
was done at any given site, the investigator met all the par-
ticipants, carried out a self-introduction, and informed the
participants about the interview’s concern with their
experiences during their latest pregnancy but did not
disclose the exact study title. This was done to minimise
recruitment bias. After the meeting, the women were
invited into a private room one at a time to receive more
details about the study objectives and the written
informed consent process. Those who gave their full
informed consent went on to complete the interviewer-
administered questionnaire while those who could not
give their consent were allowed to leave the room.
Collected data were entered on a Microsoft Excel 2007©
spreadsheet for mathematical operations such as calcula-
tion of totals, means and proportions and for construction
of tables and charts. Stata Version 8.0™ was used for
further statistical analysis. Chi Square tests were performed
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<0.05 was considered to be significant. This study was
approved by the Harare City Council Department of
Health and was deemed ethically sound by the Joint Par-
irenyatwa Hospital and University of Zimbabwe College




Participants’ ages ranged from 16–50 years old and aver-
age age was 26 years (Standard deviation = 6.1 years). All
participants were married and all had received at least
primary level education. All except three participants
cited Christianity as their religion. The rest of the char-
acteristics of the study participants are summarised in
Table 1 along with their respective p-values (as indica-
tors of significant association to prenatal use of TM).
Prevalence
In total, 248 participants at the twelve study sites were
interviewed, and of these, 129, reported that they
employed at least one traditional medicine-based inter-
vention during pregnancy. The prevalence of prenatal
use of TM within the study population was 52%
(n = 129, 95% C.I. = 44%- 60% and Standard error of
3.17%).
Patterns of use
The most commonly used traditional medicine interven-
tions, their dosing regimens and the indications for use
are summarised in Table 2. Users reported use of at least
one intervention but several used more than one as
shown in Figure 2. Among the users, the majority
(n = 96) used only a single intervention, 27 users used
two interventions concomitantly while 5 employed three
interventions. Only one user reported the use of four
interventions during a single pregnancy. Characteristics
of pregnant women which were significantly associated
with prenatal use of TM were; being in the 20–25 age
group (p = 0.021), nulliparity (p = 0.004), nulligravidity
(p = 0.002), and residing in the Mbare high density
neighbourhood (p = 0.046). Tribe of origin, religion and
level of education and employment status were not sta-
tistically significantly associated with prenatal use of
TM. This study revealed that women regarded perineal
tearing during parturition as an adverse and undesirable
event. Widening of the birth canal to prevent perineal
tearing was therefore the most common indication for
using traditional medicine during pregnancy. Perineal
tearing was reported to have been experienced by 140
participants. Other perinatal adverse events reported
were; postpartum haemorrhage (n = 2), retained placenta
(n = 1), breech birth (n = 1), prolonged labour (n = 2),eclampsia (n = 1) and erratic postnatal bleeding (n = 1).
Interestingly, it was noted that the non-use of traditional
medicine was significantly associated with experiencing
at least one adverse event, (p = 0.001). Use of TM was
not found to be significantly associated with adverse
events (p = 0.339). Other conditions which predisposed
women to adverse events (mainly perineal lacerations),
were nulliparity (p = 0.012) and nulligravidity (p = 0.029).
Almost all TM interventions were employed beginning
at the onset of the 3rd trimester and doses and dosing
intervals were rarely standardised. The most commonly
used TMs (reported to have been used by N> 10) were;
holy water, soil burrowed by moles, Pouzolzia mixta root
(nhanzva), elephant dung, cocktails of unknowns herbs
and manual exercises with various lubricants.
Discussion
This study detected 52% prevalence of prenatal use of
TM with a standard error of 3.17%, lower than the
study’s acceptable margin error of 5%. This prevalence
value is within the same range as the one reported by
Rahman and co-workers from similar work in Tumpat
district, Malaysia in 2008 (50.4%), [5] by Kalder et al., in
Germany in 2010 (50.8%) [6], by Cuzzolini and collea-
gues in Italy in the year 2010 (46.7%) [7] and by Mabina
et al. in South Africa in 1997 [8]. While similar, the
prevalence values from other studies were measuring
prenatal use of only herbal medicines as opposed to this
study which measured the use of traditional remedies as
well as consultation of traditional practitioners. This
prevalence rate of 52% is not necessarily representative
of the whole of Zimbabwe because the selection of study
sites was not random and representative of Zimbabwe.
Rather, the sites were chosen only because they were the
same sites at which the NASG clinical trial is being con-
ducted. The indications for use reported by women in
this study differed from those in reviewed literature. The
primary goal for the participants in this study seemed to
be the prevention of perineal lacerations, labour aug-
mentation and achieving a safe delivery process while
the motivation for use by women from Western coun-
tries was to treat conditions precipitated by pregnancy,
to supplement their nutritional supply and to treat the
same conditions usually treated by conventional medi-
cines [6]. Other indications reported in literature were;
increasing sexual pleasure [3], spiritual cleansing [5] and
also for lactation [9]. Because data collection was based
on what the interviewees reported, the study was vulner-
able to recall bias and possibly deliberate incorrect
answers in cases where the correct answer could be
incriminating to the participant. Only two study partici-
pants reported using Cannabis sativa (mbanje) - based
TM for labour induction. The investigator had antici-
pated this number to be higher considering that the
Table 1 Demographic characteristics of the study participants
Characteristic Frequency n (%) n= 248 P value
Users = 129 (52.02) S.E (3.17%) Non-users = 119 (47.98) SE (3.17%) Total = 248 (100)
Age (years)
<20 15 (6.05) S.E (1.51%) 7 (2.82) S.E (1.05%) 22 (8.87) S.E (0.57%) P = 0.113
20-25 60 (24.2) SE (2.72%) 37 (14.91) SE (2.26%) 97 (39.11) SE (3.1%) P = 0.021
26-30 30 (12.09) SE (2.07%) 41 (16.62) SE (2.36%) 71 (28.63) SE (2.87%) P = 0.183
31-40 21 (8.47) SE (1.77%) 30 (12.09) SE (2.07%) 51 (20.56) SE (2.57%) P = 0.206
>40 3 (1.21) SE (0.69%) 4 (1.61) SE (0.8%) 7 (2.82) SE (1.51%) P = 0.714
Level of Education
None 0 (0) 0(0) 0 (0)
Primary 7 (2.82) SE (1.05%) 6 (2.42) SE (0.98%) 13 (5.24) SE (1.41%) P = 0.7774
Secondary 114 (46) SE (3.16%) 99 (39.89) SE (3.11%) 213 (85.89) SE (2.21%) P = 0.244
Tertiary 8 (3.22) SE (1.12%) 14 (5.65) SE (1.47%) 22 (8.87) SE (0.57%) P = 0.205
Employment
Housewife 83 (33.47) SE (3.00%) 63 (23.4) SE (2.69%) 146 (56.87) SE (3.14%) P = 0.094
Self-Employed 22 (8.87) SE (0.57%) 32 (12.9) SE (2.13%) 54 (21.77) SE (2.62%) P = 0.193
Formally employed 13 (5.24) SE (1.41%) 20 (8.07) SE (1.73%) 33 (13.31) SE (2.28%) P = 0.216
Student 11 (4.44) SE (1.31%) 4 (1.61) SE (0.8%) 15 (6.05) SE (1.51%) P = 0.107
Parity
1 58 (23.39) SE (2.69%) 29 (11.69) SE (2.04%) 87 (35.08) SE (3.03%) P = 0.004
2 45 (18.15) SE (2.45%) 45 (18.15) SE (2.45%) 90 (36.29) SE (3.05%) P = 1.000
3 20 (8.06) SE (1.73%) 36 (14.52) SE (2.24%) 56 (22.58) SE (2.65%) P = 0.044
4 5 (2.02) SE (0.89%) 7 (2.82) SE (1.05%) 12 (4.84) SE (1.36%) P = 0.585
5 1 (0.41) SE (0.41%) 1 (0.41) SE (0.41%) 2 (0.81) SE (0.57%) P =−*
6 0 (0) 1 (0.41) SE (0.41%) 1 (0.40) SE (0.41%) P =−*
Gravida
1 52 (21) SE (2.59%) 23 (9.27) SE (1.84) 75 (30.24) SE (2.92%) P = 0.002
2 41 (16.5) SE (2.36%) 43 (17.34) SE (2.4%) 84 (33.87) SE (3.00%) P = 0.855
3 27 (10.89) SE (1.98%) 40 (16.13) SE (2.34%) 67 (27.02) SE (2.82%) P = 0.108
4 8 (3.23) SE (1.12%) 10 (4.03)SE (1.25%) 18 (7.26) SE (1.65%) P = 0.555
5 1 (0.41) SE (0.41%) 1 (0.41) SE (0.41%) 2 (0.81) SE (0.57%) P =−*
6 2 (0.81) SE (0.57%) 0 (0) 2 (0.81) SE (0.57%) P =−*
Tribe
Zezuru 60 (24.19) SE (2.72%) 55 (22.18) SE (2.64%) 115 (46.37) SE (3.17%) P = 0.668
Karanga 18 (7.26) SE (1.65%) 14 (5.64) SE (1.47%) 32 (12.90) SE (2.13%) P = 0.558
Maungwe 12 (4.84) SE (1.36%) 11 (4.43) SE (1.31%) 23 (9.27) SE (1.84%) P = 0.661
Manyika 9 (3.63) SE (1.19%) 14 (5.64) SE (1.47%) 23 (9.27) SE (1.84) P = 0.303
Ndebele 5 (2.02) SE (0.89%) 4 (1.61) SE (0.8%) 9 (3.63) SE (1.19%) P = 0.720
Korekore 13 (5.24) SE (1.41%) 11 (4. 44) SE (1.31%) 24 (9.68) SE (1.88%) P = 0.696
Ndau 2 (0.81) SE (0.57%) 3 (1.21) SE (0.69%) 5 (2.02) SE (0.89%) P = 0.661
Toko 7 (2.82) S.E (1.05%) 4 (1.61) SE (0.8%) 11 (4.44) SE (1.31%) P = 0.370
Foreigner 3 (1.21) SE (0.69%) 3 (1.21) SE (0.69%) 6 (2.42) SE (0.98%) P = 1.000
Area of Residence
Budiriro 11 (4.44) SE (1.31%) 9 (3.63) SE (1.19%) 20 (8.06) SE (1.73%) P = 0.656
Mbare 15 (6.05) SE (1.51%) 5 (2.02) SE (0.89%) 20 (8.06) SE (1.73%) P = 0.046
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Table 1 Demographic characteristics of the study participants (Continued)
Glen View 12 (4.84) SE (1.36%) 8 (3.22) SE (1.12%) 20 (8.06) SE (1.73%) P = 0.380
Hatcliffe 11 (4.44) SE (1.31%) 9 (3.63) SE (1.19%) 20 (8.06) SE (1.73%) P = 0.656
Highfield 24 (9.68) SE (1.88%) 19 (7.66) SE (1.69%) 43 (17.34) SE (2.4%) P = 0.443
Kambuzuma 12 (4.84) SE (1.36%) 8 (3.22) SE (1.12%) 20 (8.06) SE (1.73%) P = 0.380
Kuwadzana 9 (3.63) SE (1.19%) 11 (4.44) SE (1.31%) 20 (8.06) SE (1.73%) P = 0.656
Mabvuku/Tafara 6 (2.42) SE (0.98%) 14 (5.64) SE (1.47%) 20 (8.06) SE (1.73%) P = 0.097
Mufakose 10 (4.03) SE (1.25%) 15 (6.05) SE (1.51%) 25 (10.08) SE (1.73%) P = 0.327
Dzivarasekwa 6 (2.42) SE (0.98%) 14 (5.64) SE (1.47%) 20 (8.06) SE (1.73%) P = 0.097
Warren Park 13 (5.24) SE (1.41%) 7 (2.82) S.E (1.05%) 20 (8.06) SE (1.73%) P = 0.199
* Not enough observations to test for significance. Table 1 shows the demographic characteristics of the study population; their age, level of education and
employment status according to whether they were prenatal users of TM interventions (users) or non-users.
SE = Standard Error.
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their subjects reported its use frequently. Because use of
Cannabis sativa is an illicit practice according to the
Medicines and Allied Substances Control Act Chapter
15:03 of Zimbabwe, participants could have been de-
terred from reporting that they used it regardless of the
confidentially agreement.Table 2 Patterns of prenatal use of TM within the study popu
Intervention Dosing regimen
Holy water Drunk in 3rd trimester or throughout pregna
patient’s discretion.
Soil from burrowing mole Soil is mixed with water and the supernatan
the 3rd trimester
Pouzolzia mixta (nhanzva) Aqueous extract of root is applied intravagin
manual exercises to dilate the birth canal.
Elephant Dung Dung is mixed with water and variable amo
during the 3rd trimester
Unknown herbs/
concoctions
Unspecified amounts are taken during the 3




Cooked and taken orally in the 3rd trimester
Hot water/steam baths Taken inconsistently during the 3rd trimester
Cannabis sativum
(mbanje)
Aqueous extract is drunk as soon as labour c
Dicerocaryum
zanguebarium (ruredzo)
Administered both orally and intravaginally i
Castor oil 5 ml taken at night daily in 3rd trimester
Rooibos Tea Taken frequently throughout the pregnancy
Other* Varying methods
*Other interventions used by participants: “church-made” coffee (n = 1), Albizia am
warm water drinks (n = 4), ricinus communis root (n = 1), avocado seeds (n - 1), ap
and the dosing regimens employed, the stage of pregnancy in which the intervent
intervention. NB: * denotes “Other interventions” used by participants: “church-mad
(n = 1), hare droppings (n = 1), warm water drinks (n = 4), ricinus communis root (nThe study population was almost homogeneous as far
as demographic characteristics were concerned. All except
three participants cited Christianity as their religion and
all reported that they had received at least primary level
education with the majority (86%) reporting that they had
received education only up to the secondary level. The
mere location of the study sites meant that the womenlation
Indication(s)
ncy in amounts which are at the • For protection against evil spirits
• For a safe and uneventful delivery
t is drunk in varying amounts in For widening of birth canal to
avoid perineal tearing
ally in 3rd trimester, usually with For widening of birth canal to
avoid perineal tearing
unts of the supernatant are drunk For widening of birth canal to
avoid perineal tearing
rd trimester or even during labour • For widening of birth canal
• For labour induction
, warm water or Poulozozia mixta, Dilation of birth canal to avoid
tearing
. • Nutrition
• Widening of birth canal
Birth canal dilatation
ommences Labour induction to speed up
the labour
n the 3rd trimester Widening of birth canal to avoid
tearing
For constipation and labour
induction
For widening of birth canal to
avoid tearing
Widening of birth canal and
labour induction
ara (muora) (n = 1), Terminalia sericea (mususu) (n = 1), hare droppings (n = 1),
ple seeds (n = 1), Table 2 shows the traditional medicine interventions used
ion was used and the number of participants (n) who reported using the
e” coffee (n = 1), Albizia amara (muora) (n = 1), Terminalia sericea (mususu)
= 1), avocado seeds (n-1), apple seeds (n = 1).
Figure 2 The number of women who used different numbers
of TMs concurrently during their pregnancies. Figure 2 shows
the number of women who used different numbers of traditional
medicine interventions during their pregnancy. Among users, the
majority (n = 96) used only a single intervention, 27 users used two
interventions concomitantly while 5 employed three interventions.
Only one user reported the use of four interventions during a
single pregnancy.
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dential areas, which might limit generalizability of the
results. The most commonly used TM interventions
reported in this study were not consistent with those
reported by any of the literature reviewed prior to data
collection. This emphasized the need for every region to
perform its own study because results from different parts
of the world were not necessarily analogous. Nulliparity
and nulligravidity were found to be significantly associated
with prenatal use of TM, possibly because without prior
experience, nullipara women were prone to accepting ad-
vice concerning their pregnancy. Nulliparity and nulligra-
vidity were also predisposing factors to experiencing
adverse events, mostly perineal tears, just as Lindgren and
co-workers highlighted [10]. The authors could not fully
establish why residing in the Mbare neighbourhood was
significantly associated with prenatal use of TM. However,
it could be postulated to be due to the close proximity of
Mbare to Harare’s largest population of informal vendors,
including TM vendors (Mbare Musika).
Conclusions
Based on the findings of this study, it was concluded
that, the prevalence of prenatal use of traditional medi-
cine among women seen at the selected Harare clinics
was 52% at a standard error of 3.17%. Of these users, the
majority (N= 96) used a single intervention while others
used two or more. Pregnant women in Harare’s high
density residential areas used TM practices to induce
labour, avoid perineal tearing and improve the safety of
their delivery process.
This study alone did not address the query which the
NASG Clinical Trial team raised concerning a possible
link between excessive postpartum bleeding and prenatal
use of traditional medicine. However, because the most
commonly used TM interventions were identified in thisstudy, further extensive literature searches and in-vitro
studies could follow. Characteristics of pregnant women
which were significantly associated with prenatal use of
TM were; being in the 20–25 age group (p = 0.021), nul-
liparity (p = 0.004), nulligravidity (p = 0.002), and residing
in Mbare (p = 0.046). Statistically, the tribe of origin, reli-
gion and level of education and employment status were
not significantly associated with prenatal use of TM.
Non-use of TM, nulliparity and nulligravidity were
found to be significantly associated with experiencing
adverse events while use of TM was not. Because pre-
natal use of TM was fairly common practice while those
participants who claimed non-use of TM reported ex-
periencing more adverse events, further confirmatory
studies with more refined designs such as case–control,
cohort or animal studies would be warranted. Such stud-
ies would determine which medicines, if any, were pro-
tective against or causative of obstetric adverse events,
hence establish the possible mechanism of action and
provide the necessary clinical evidence for encouraging
or discouraging the prenatal use of TM.
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